FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198751520> ?p ?o ?g. }

• W3198751520 endingPage "1379" @default.
• W3198751520 startingPage "1379" @default.
• W3198751520 abstract "Nanotechnology-based drug delivery systems are an emerging technology for the targeted delivery of chemotherapeutic agents in cancer therapy with low/no toxicity to the non-cancer cells. With that view, the present work reports the synthesis, characterization, and testing of Mn:ZnS quantum dots (QDs) conjugated chitosan (CS)-based nanocarrier system encapsulated with Mitomycin C (MMC) drug. This fabricated nanocarrier, MMC@CS-Mn:ZnS, has been tested thoroughly for the drug loading capacity, drug encapsulation efficiency, and release properties at a fixed wavelength (358 nm) using a UV–Vis spectrophotometer. Followed by the physicochemical characterization, the cumulative drug release profiling data of MMC@CS-Mn:ZnS nanocarrier (at pH of 6.5, 6.8, 7.2, and 7.5) were investigated to have the highest release of 56.48% at pH 6.8, followed by 50.22%, 30.88%, and 10.75% at pH 7.2, 6.5, and 7.5, respectively. Additionally, the drug release studies were fitted to five different pharmacokinetic models including pesudo-first-order, pseudo-second-order, Higuchi, Hixson–Crowell, and Korsmeyers–Peppas models. From the analysis, the cumulative MMC release suits the Higuchi model well, revealing the diffusion-controlled mechanism involving the correlation of cumulative drug release proportional to the function square root of time at equilibrium, with the correlation coefficient values (R2) of 0.9849, 0.9604, 0.9783, and 0.7989 for drug release at pH 6.5, 6.8, 7.2, and 7.5, respectively. Based on the overall results analysis, the formulated nanocarrier system of MMC synergistically envisages the efficient delivery of chemotherapeutic agents to the target cancerous sites, able to sustain it for a longer time, etc. Consequently, the developed nanocarrier system has the capacity to improve the drug loading efficacy in combating the reoccurrence and progression of cancer in non-muscle invasive bladder diseases." @default.
• W3198751520 created "2021-09-13" @default.
• W3198751520 creator A5003969209 @default.
• W3198751520 creator A5014802511 @default.
• W3198751520 creator A5026583282 @default.
• W3198751520 creator A5066152221 @default.
• W3198751520 creator A5069265677 @default.
• W3198751520 creator A5073751680 @default.
• W3198751520 creator A5075531224 @default.
• W3198751520 creator A5080418185 @default.
• W3198751520 date "2021-08-31" @default.
• W3198751520 modified "2023-10-18" @default.
• W3198751520 title "Drug Release Profiles of Mitomycin C Encapsulated Quantum Dots–Chitosan Nanocarrier System for the Possible Treatment of Non-Muscle Invasive Bladder Cancer" @default.
• W3198751520 cites W1979589467 @default.
• W3198751520 cites W1986834929 @default.
• W3198751520 cites W2039385749 @default.
• W3198751520 cites W2041438258 @default.
• W3198751520 cites W2189070656 @default.
• W3198751520 cites W2216788151 @default.
• W3198751520 cites W2414781026 @default.
• W3198751520 cites W2536590606 @default.
• W3198751520 cites W2565180271 @default.
• W3198751520 cites W2610485393 @default.
• W3198751520 cites W2618037986 @default.
• W3198751520 cites W2709682239 @default.
• W3198751520 cites W2740839736 @default.
• W3198751520 cites W2742287127 @default.
• W3198751520 cites W2765916778 @default.
• W3198751520 cites W2765935920 @default.
• W3198751520 cites W2766940634 @default.
• W3198751520 cites W2774577787 @default.
• W3198751520 cites W2784999813 @default.
• W3198751520 cites W2785881131 @default.
• W3198751520 cites W2803642751 @default.
• W3198751520 cites W2807736295 @default.
• W3198751520 cites W2811503057 @default.
• W3198751520 cites W2890170774 @default.
• W3198751520 cites W2901919387 @default.
• W3198751520 cites W2909246894 @default.
• W3198751520 cites W2912642182 @default.
• W3198751520 cites W2919672145 @default.
• W3198751520 cites W2927955149 @default.
• W3198751520 cites W2937912908 @default.
• W3198751520 cites W2947544769 @default.
• W3198751520 cites W2947742313 @default.
• W3198751520 cites W2971231547 @default.
• W3198751520 cites W2982127577 @default.
• W3198751520 cites W2994236098 @default.
• W3198751520 cites W2995816338 @default.
• W3198751520 cites W3002092157 @default.
• W3198751520 cites W3005371493 @default.
• W3198751520 cites W3006626595 @default.
• W3198751520 cites W3010311208 @default.
• W3198751520 cites W3010963046 @default.
• W3198751520 cites W3031781184 @default.
• W3198751520 cites W3033290635 @default.
• W3198751520 cites W3036012322 @default.
• W3198751520 cites W3040056002 @default.
• W3198751520 cites W3043858521 @default.
• W3198751520 cites W3048299223 @default.
• W3198751520 cites W3081360217 @default.
• W3198751520 cites W3082509743 @default.
• W3198751520 cites W3088792706 @default.
• W3198751520 cites W3093577416 @default.
• W3198751520 cites W3097643838 @default.
• W3198751520 cites W3107987849 @default.
• W3198751520 cites W3108277730 @default.
• W3198751520 cites W3114815433 @default.
• W3198751520 cites W3123787387 @default.
• W3198751520 cites W3131851471 @default.
• W3198751520 cites W3135005331 @default.
• W3198751520 cites W3135518153 @default.
• W3198751520 cites W3138006731 @default.
• W3198751520 cites W3185552296 @default.
• W3198751520 doi "https://doi.org/10.3390/pharmaceutics13091379" @default.
• W3198751520 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8469644" @default.
• W3198751520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34575455" @default.
• W3198751520 hasPublicationYear "2021" @default.
• W3198751520 type Work @default.
• W3198751520 sameAs 3198751520 @default.
• W3198751520 citedByCount "17" @default.
• W3198751520 countsByYear W31987515202021 @default.
• W3198751520 countsByYear W31987515202022 @default.
• W3198751520 countsByYear W31987515202023 @default.
• W3198751520 crossrefType "journal-article" @default.
• W3198751520 hasAuthorship W3198751520A5003969209 @default.
• W3198751520 hasAuthorship W3198751520A5014802511 @default.
• W3198751520 hasAuthorship W3198751520A5026583282 @default.
• W3198751520 hasAuthorship W3198751520A5066152221 @default.
• W3198751520 hasAuthorship W3198751520A5069265677 @default.
• W3198751520 hasAuthorship W3198751520A5073751680 @default.
• W3198751520 hasAuthorship W3198751520A5075531224 @default.
• W3198751520 hasAuthorship W3198751520A5080418185 @default.
• W3198751520 hasBestOaLocation W31987515201 @default.
• W3198751520 hasConcept C13965031 @default.
• W3198751520 hasConcept C141071460 @default.
• W3198751520 hasConcept C163588942 @default.
• W3198751520 hasConcept C171250308 @default.

• next